The objective of these proceedings was to provide a platform for the exchange of information on the design, construction and operation of fusion experiments. The technology which is being developed for the next step devices and fusion reactors was also covered.

Magnetic Fusion Technology describes the technologies that are required for successful development of nuclear fusion power plants using strong magnetic fields. These technologies include: • magnet systems, • plasma heating systems, • control systems, • energy conversion systems, • advanced materials development, • vacuum systems, • cryogenic systems, • plasma diagnostics, • safety systems, and • power plant design studies. Magnetic Fusion Technology will be useful to students and to specialists working in energy research.

This second edition of a popular textbook is thoroughly revised with around 25% new and updated content. It provides an introduction to both plasma physics and fusion technology at a level that can be understood by advanced undergraduates and graduate students in the physical sciences and related engineering disciplines. As such, the contents cover various plasma confinement concepts, the support technologies needed to confine the plasma, and the designs of ITER as well as future fusion reactors. With end of chapter problems for use in courses.

The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs—with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein for human use, approved by the FDA in 1982 and Orthoclone® the first monoclonal antibody reaching the market in 1986. These first generation molecules were soon followed by a plethora of recombinant copies of natural human proteins, and in 1998, the first de novo designed fusion protein was launched. Fusion Protein Technologies for Biopharmaceuticals examines the state of the art in developing fusion proteins for biopharmaceuticals, shedding light on the immense potential inherent in fusion protein design and functionality. A wide pantheon of international scientists and researchers deliver a comprehensive and complete overview of therapeutic fusion proteins, combining the success stories of marketed drugs with the dynamic preclinical and clinical research into novel drugs designed for as yet unmet medical needs. The book covers the major types of fusion proteins—receptor-traps, immunotoxins, Fc-fusions and peptibodies—while also detailing the approaches for developing, delivering, and improving the stability of fusion proteins. The main body of the book contains three large sections that address issues key to this specialty: strategies for extending the plasma half life, the design of toxic proteins, and utilizing fusion proteins for ultra specific targeting. The book concludes with novel concepts in this field, including examples of highly relevant multifunctional antibodies. Detailing the innovative science, commercial realities, and brilliant potential of fusion protein therapeutics, Fusion Protein Technologies for Biopharmaceuticals is a must for pharmaceutical scientists, biochemists, medicinal chemists, molecular biologists, pharmacologists, and genetic engineers interested in determining the shape of innovation in the world of biopharmaceuticals.

'The text provides an interesting history of previous and anticipated accomplishments, ending with a chapter on the relationship of fusion power to nuclear weaponry. They conclude on an optimistic note, well worth being understood by the general public.'CHOICEThe gap between the state of fusion energy research and public understanding is vast. In an entertaining and engaging narrative, this popular science book gives readers the basic tools to understand how fusion works, its potential, and contemporary research problems.Written by two young researchers in the field, The Future of Fusion Energy explains how physical laws and the Earth's energy resources motivate the current fusion program — a program that is approaching a critical point. The world's largest science project and biggest ever fusion reactor, ITER, is nearing completion. Its success could trigger a worldwide race to build a power plant, but failure could delay fusion by decades. To these ends, this book details how ITER's results could be used to design an economically competitive power plant as well as some of the many alternative fusion concepts.

The objective of the Symposium on Fusion Technology (SOFT) conference is to set the stage for the exchange of information on the design, construction, and operation of fusion experiments and the technology which is being developed for the next-step devices and for fusion reactors. These proceedings therefore present an up-to-date and throrough review of the state-of-the art in this dynamic field.